DeLong, Allison   MS

Scientific Research Staff

Biostatistician and Core Coordinator
Brown University
Box G-S121-7
121 S. Main Street
Providence, RI 02912
Phone: 401-863-9697
Fax: 401-863-9182
Email: adelong@stat.brown.edu




DeLong, Allison

Education:

M.S. Statistics, University of Rhode Island, Kingston, RI - 2003 M.S. Applied Mathematics/Modeling, Humboldt State University, Arcata, CA - 1995 B.A. Mathematics and Russian, Grinnell College, Grinnell, IA - 1991

Current Projects:

Biostatistics Core, Center for AIDS Research

Recent Publications:

Diero L, Mann M, Kemboi E, Mambo F, Rono M, Injera W, DeLong AK, Schreier L, Kaloustian KW, Sidle JE, Buziba N, Kantor R. Antiretroviral Treatment Interruptions Induced by the Kenyan Post-Election Crisis are Associated with Virologic Failure. Submitted. 

Taylor LE, Gholam PM, DeLong AK, Klein RS, Cintron V, Wu Z, Blackard JT, Rompalo A, Sobel J, Lazarus TS, Carpenter CJ, Wands JR. Occult hepatitis B virus in women with or at risk for HIV infection. Submitted.

Venkatesh KK, DeLong AK, Kantor R, Chapman S, Ingersoll J, Kurpewski J, De Pasquale MP, D'Aquila R, Caliendo AM, Cu-Uvin S. Women failing HAART with detectable plasma viral load continue to have genital tract HIV-1 RNA shedding despite changing HAART regimens. Accepted to Journal of Women's Health..

DeLong AK, Blossom BP, Maloney E, Phillips SE. Antibiotic retreatment of Lyme disease in patients with persistent symptoms: a biostatistical review of randomized, placebo-controlled, clinical trials. Contemporary Clinical Trials. 2012; 33(6): 1132-42.DOI: 10.1016/j.cct.2012.08.009.

DeLong AK, Wu M, Bennett D, Parkin N, Wu Z, Hogan JW, Kantor R. Sequence Quality Analysis Tool for HIV Type 1 Protease and Reverse Transcriptase. AIDS research and human retroviruses. 2012; 28(8): 894-901.DOI: 10.1089/AID.2011.0120. PMID: 21916749

Huang A, Hogan JW, Istrail S, DeLong A, Katzenstein DA, Kantor R. Global analysis of sequence diversity within HIV-1 subtypes across geographic regions. Future Virol. 2012; 7(5): 505-17.Doi 10.2217/Fvl.12.37.

Nijhawan A, Delong A, Chapman S, Rana AI, Kurpewski J, Ingersoll J, Caliendo AM, Cu-Uvin S. Effect of HSV-2 Suppressive Therapy on Genital Tract HIV-1 RNA Shedding among Women on HAART: A Pilot Randomized Controlled Trial. Infectious diseases in obstetrics and gynecology. 2012.DOI: 10.1155/2012/868526. PMC3299258

Westley BP, Delong AK, Tray CS, Sophearin D, Dufort EM, Nerrienet E, Schreier L, Harwell JI, Kantor R. Prediction of Treatment Failure Using 2010 World Health Organization Guidelines Is Associated With High Misclassification Rates and Drug Resistance Among HIV-Infected Cambodian Children. Clin Infect Dis. 2012; 55(3): 432-40.DOI: 10.1093/cid/cis433. PMID: 22539664

Winston SE, Montague BT, Lopez M, DeLong AK, Le Marchand C, Bedoya A, Gillani F, Beckwith CG. Evaluation of longitudinal clinical outcomes and adherence to care among HIV-infected refugees. International Association of Physicians in AIDS Care (JIAPAC). 2012.DOI: 10.1177/1545109712459680.

El-Khatib Z, Delong AK, Katzenstein D, Ekstrom AM, Ledwaba J, Mohapi L, Laher F, Petzold M, Morris L, Kantor R. Drug resistance patterns and virus re-suppression among HIV-1 subtype C infected patients receiving non-nucleoside reverse transcriptase inhibitors in South Africa. Journal of AIDS & clinical research. 2011; 2(117).DOI: 10.4172/2155-6113.1000117. PMC3174802

Huang A, Kantor R, Delong A, Schreier L, Sorin I. QColors: An alogorithm for conservative viral quasispecies reconstruction from short and non-contiguous next generation sequencing reads. BIBMW. 2011: 130-6.DOI: 10.1109/BIBMW.2011.6112365.

Nijhawan AE, DeLong AK, Celentano DD, Klein RS, Sobel JD, Jamieson DJ, Cu-Uvin S. The association between Trichomonas infection and incarceration in HIV-seropositive and at-risk HIV-seronegative women. Sexually transmitted diseases. 2011; 38(12): 1094-100.DOI: 10.1097/OLQ.0b013e31822ea147. PMID: 22082718

Stricker RB, DeLong AK, Green CL, Savely VR, Chamallas SN, Johnson L. Benefit of intravenous antibiotic therapy in patients referred for treatment of neurologic Lyme disease. International journal of general medicine. 2011; 4: 639-46.10.2147/IJGM.S23829. 3177589

Tate DF, Delong A, McCaffrey DE, Kertesz K, Paul RH, Conley J, Russell T, Coop K, Gillani F, Flanigan T, Tashima K, Hogan JW. Recent clinical history and cognitive dysfunction for attention and executive function among human immunodeficiency virus-infected patients. Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists. 2011; 26(7): 614-23.DOI: 10.1093/arclin/acr065. PMC3243921

Taylor LE, DeLong AK, Maynard MA, Chapman S, Gholam P, Blackard JT, Rich J, Mayer KH. Acute hepatitis C virus in an HIV clinic: a screening strategy, risk factors, and perception of risk. AIDS patient care and STDs. 2011; 25(10): 571-7.DOI: 10.1089/apc.2011.0106. PMC3183653

Beckwith CG, Liu T, Bazerman LB, DeLong AK, Desjardins SF, Poshkus MM, Flanigan TP. HIV risk behavior before and after HIV counseling and testing in jail: a pilot study. Journal of acquired immune deficiency syndromes (1999). 2010; 53(4): 485-90.DOI: 10.1097/QAI.0b013e3181c997b1. PMC2837107

Cu-Uvin S, DeLong AK, Venkatesh KK, Hogan JW, Ingersoll J, Kurpewski J, De Pasquale MP, D'Aquila R, Caliendo AM. Genital tract HIV-1 RNA shedding among women with below detectable plasma viral load. AIDS (London, England). 2010; 24(16): 2489-97.DOI: 10.1097/QAD.0b013e32833e5043. PMID: 20736815

Eleanya C, Delong AK, Chapman S, Nijhawan A, Ingersoll J, Caliendo AM, Cu-Uvin S. Addition of Acyclovir does not affect Adherence to HAART in HIV-1/ HSV-2 Co-Infected Women. Journal of AIDS & Clinical Research. 2010; 1(4): 113.DOI: doi: 10.4172/2155-6113.1000113. PMC3093536

Beckwith CG, DeLong AK, Desjardins SF, Gillani F, Bazerman L, Mitty JA, Ross H, Cu-Uvin S. HIV infection in refugees: a case-control analysis of refugees in Rhode Island. Int J Infect Dis. 2009; 13(2): 186-92.DOI: 10.1016/j.ijid.2008.06.004. PMC2704558

Kantor R, Diero L, Delong A, Kamle L, Muyonga S, Mambo F, Walumbe E, Emonyi W, Chan P, Carter EJ, Hogan J, Buziba N. Misclassification of first-line antiretroviral treatment failure based on immunological monitoring of HIV infection in resource-limited settings. Clin Infect Dis. 2009; 49(3): 454-62.DOI: 10.1086/600396. PMID: 19569972

Land S, Cunningham P, Zhou J, Frost K, Katzenstein D, Kantor R, Chen YM, Oka S, DeLong A, Sayer D, Smith J, Dax EM, Law M. TREAT Asia Quality Assessment Scheme (TAQAS) to standardize the outcome of HIV genotypic resistance testing in a group of Asian laboratories. Journal of virological methods. 2009; 159(2): 185-93.DOI: 10.1016/j.jviromet.2009.03.016. PMC2863146

Moreira C, Venkatesh KK, DeLong A, Liu T, Kurpewski J, Ingersoll J, Caliendo AM, Cu-Uvin S. Effect of treatment of asymptomatic bacterial vaginosis on HIV-1 shedding in the genital tract among women on antiretroviral therapy: a pilot study. Clin Infect Dis. 2009; 49(6): 991-2.DOI: 10.1086/605540. PMC2730467

Anderson BL, Wang CC, Delong AK, Liu T, Kojic EM, Kurpewski J, Ingersoll J, Mayer K, Caliendo AM, Cu-Uvin S. Genital tract leukocytes and shedding of genital HIV type 1 RNA. Clin Infect Dis. 2008; 47(9): 1216-21.DOI: 10.1086/592303. PMC2714169

Kwara A, DeLong A, Rezk N, Hogan J, Burtwell H, Chapman S, Moreira CC, Kurpewski J, Ingersoll J, Caliendo AM, Kashuba A, Cu-Uvin S. Antiretroviral drug concentrations and HIV RNA in the genital tract of HIV-infected women receiving long-term highly active antiretroviral therapy. Clin Infect Dis. 2008; 46(5): 719-25.

Merchant RC, Mayer KH, Becker BM, Delong AK, Hogan JW. Predictors of the initiation of HIV postexposure prophylaxis in Rhode Island emergency departments. AIDS patient care and STDs. 2008; 22(1): 41-52.DOI: 10.1089/apc.2007.0031. PMC3206608

Merchant RC, Phillips BZ, Delong AK, Mayer KH, Becker BM. Disparities in the provision of sexually transmitted disease and pregnancy testing and prophylaxis for sexually assaulted women in Rhode Island emergency departments. Journal of women's health (2002). 2008; 17(4): 619-29.DOI: 10.1089/jwh.2007.0472. PMC3180868

Macalino GE, Hogan JW, Mitty JA, Bazerman LB, Delong AK, Loewenthal H, Caliendo AM, Flanigan TP. A randomized clinical trial of community-based directly observed therapy as an adherence intervention for HAART among substance users. AIDS (London, England). 2007; 21(11): 1473-7. PMID: 17589194

Rich JD, Hogan JW, Wolf F, DeLong A, Zaller ND, Mehrotra M, Reinert S. Lower syringe sharing and re-use after syringe legalization hode Island. Drug and alcohol dependence. 2007; 89(2-3): 292-7. PMID: 17386980


 

Recent Abstracts:

Lagat DK, Carter EJ, DeLong AK, Kimaiyo S, Velazquez E and Sherman CB. The Relationship of Indoor Air Pollution (IAP) Exposure to Isolated Right Heart Failure (IRHF) in Women of Western Kenya: A Pilot Study.  ATS 2012 International Conference of the American Thoracic Society; May 18-23, 2012, San Francisco, CA.

Kantor R, Schreier L, Lloyd R, Kumarasamy N, Phanuphak P, Zhang F, Diero L, Balamane M, DeLong AK and Katzenstein D. Sampletanker and Plasma Genotyping of Diverse HIV-1 Subtypes from Multiple Geographic Regions.  International AIDS Conference (IAS) 2012; July 22-27, 2012, Washington DC.

Westley BP, DeLong AK, Soeung S, Chhraing T, Dim S, Nerrienet E, Schreier L and Kantor R. Extensive drug resistance in HIV-infected Cambodian children failing first-line antiretroviral therapy is Undetected by WHO 2010 guidelines.  19th Conference on Retroviruses and Opportunistic Infections (CROI); March 5-8, 2012, Seattle, Washington.

Mann M, Diero L, Kemboi E, Rono M, Mambo F, Injera W, DeLong AK, Schreier L, Buziba N and Kantor R. Unplanned Antiretroviral Treatment Interruptions Induced by the Kenyan Post-Election Crisis are Associated with HIV virological Failure.  19th Conference on Retroviruses and Opportunistic Infections (CROI); March 5-8, 2012, Seattle, Washington.

Taylor LE, Maynard MA, Foont JA, Chapman S, DeLong AK, Wurcell A, Cu-Uvin S and Mayer KH. The Spectrum of New Hepatitis C Virus (HCV) Diagnoses in a U.S. HIV Clinic.  HIV and Liver Disease 4th Biennial Meeting; Sept 6-8, 2012, Jackson, WY.

Rogo T, DeLong AK, Chan PA and Kantor R. High levels of Diversity and Drug resistance in the only Pediatric HIV Clinic in Rhode Island.  20th Annual Lifespan Research Celebration; Oct. 11, 2012, Providence, RI.

Rogo T, DeLong AK, Chan PA and Kantor R. High levels of Diversity and Drug resistance in the only Pediatric HIV Clinic in Rhode Island.  IDWeek 2012, a joint meeting of IDSA, SHEA, HIVMA and PIDS; Oct 17-21, 2012, San Diego, CA.

Nijhawan A, McManus J, Liu T, DeLong A, Chapman S, Rapoza K, Kurpewski J, Caliendo A and Cu-Uvin S. The effect of Acyclovir on CD4 Count and CD4 Percent Slope in HIV-1/HSV-2 Co-infected Women Taking Highly Active Antiretroviral Therapy (HAART).  47th IDSA Annual Meeting; Oct. 29-Nov. 1, 2009, Philadelphia, PA.

McManus J, Nijhawan A, Liu T, DeLong A, Chapman S, Rapoza K, Kurpewski J, Caliendo A and Cu-Uvin S. The Effect of Acyclovir on the Prevalence of Bacterial Vaginosis on HIV-1/HSV-2 Co-infected Women Taking Highly Active Antiretroviral Therapy (HAART).  47th IDSA Annual Meeting; Oct. 29-Nov. 1, 2009, Philadelphia, PA.

Kantor R, DeLong A, Ledwaba J, Kamau A, Seebregts C, de Oliveira T, Hogan J, Morris L and Katzenstein DftSATaRNS. Association Between Mutations Affects Drug Resistance Selection by Single-dose Nevirapine in HIV-1 Subtype C.  XVIII International HIV Drug Resistance Workshop: Basic Principles and Clinical Implications; June 9-13, 2009, Fort Myers, FL.

Kantor R, Diero L, DeLong A, Balamane M, Lloyd R, Injera W, Kamle L, Mambo F, Muyonga S, Watetu L, Carter J, Katzenstein D, Hogan J and Buziba N. HIV Diversity and Drug Resistance in Western Kenya From Plasma and non-Plasma Genotyping.  XVIII International HIV Drug Resistance Workshop: Basic Principles and Clinical Implications; June 9-13, 2009, Fort Myers, FL.

Harwell J, Lim K, DeLong A, Srey P, Thay S, Tharpe L, Ingersoll J, Caliendo A and Cu-Uvin S. Plasma (PVL) and genital tract (GTVL) viral load changes in Cambodian women during 18 months of ART.  9th annual ICAAP (International Congress on AIDS in Asia and the Pacific) conference; Aug 9-13, 2009, Bali, Indonesia.

Beckwith CG, Liu T, Bazerman LB, Delong AK, Pinkston M, Nunn A and Flanigan TP. Identification of multiple HIV risk factors among jail detainees.  2009 National HIV Prevention Conference; Aug 23-29, 2009, Atlanta, GA.

Taylor LE, DeLong AK, Gholam PM, Rodriguez I, Shah R, Wohlschlegel W, Chapman S, Ducharme RB, Chapin K and Rich JD. Screening for Acute Hepatitis C Virus (AHCV) Infection among At-Risk Patients in an HIV Clinic.  13th International Symposium on Viral Hepatitis and Liver Disease; March 20-24, 2009, Washington, DC.

Tate DF, DeLong A, Paul RH, Kertesz K, Conley J, Russell T, Price J, McCaffrey D, Coop K, Tashima K, Flanigan T and Hogan J. One Year Clinical History of CD4 and Viral Load Measures Predicts Current Cognitive Performance Among HIV-Infected Patients.  16th Conference on Retroviruses and Opportunistic Infections (CROI); Feb. 8-11, 2009, Montreal, Canada.

Cu-Uvin S, DeLong A, Perez D, Ingersoll J, Kurpewski J, Kojic E and Caliendo A. Patterns of HIV-1 RNA rebound in the blood and female genital tract.  16th Conference on Retroviruses and Opportunistic Infections (CROI); Feb. 8-11, 2009, Montreal, Canada.

Hixon M, Santos-Ahmed J, DeLong A and Wu Z. Akt1-dependent gene changes are associated with blood-testis-barrier (BTB) formation following exposure to a postnatal goitrogen.  Society of Toxicology 48th Annual Meeting (SOT); Mar. 15-19, 2009, Baltimore, MD.

Moyer B, DeLong A, Wu Z, Schorl C and Hixon M. Akt1 Mediates Epigenetic Regulation via Histone Modifcations in the Postnatal Testis.  Society of Toxicology 48th Annual Meeting (SOT); Mar. 15-19, 2009, Baltimore, MD.

Tate DF, DeLong A, Kertezse K, Conley J, Paul R, Russell T, Price J, Tashima K, Flanigan T and Hogan JW. 12-Month History of Plasma CD4 Counts is Predictive of Attention and Executive Function Performance for HIV-Infected Patients.  International Neuropsychological Society 37th Annual INS Meeting; February 11-14, 2009, Atlanta, GA.

Taylor LE, Delong A, Grebely J, Maynard MA and Treloar C. Patient perspectives and facilitators of HCV treatment for HIV/HCV coinfected persons in Rhode Island.  19th Annual Hospital Research Celebration, Rhode Island Hospital; October 27, 2011, Providence, RI.

Maynard MA, Grebely J, Delong A, Treloar C and Taylor LE. Barriers to the treatment of Hepatitis C virus infection among people with HIV/HCV coinfection in Rhode Island, United States.  Second International Symposium of Hepatitis Care in Substance Users; September 15-16, 2011, Brussels, Belgium.

Taylor LE, Delong A, Grebely J, Maynard MA and Treloar C. Patient perspectives and facilitators of HCV treatment of HIV/HCV coinfected persons in Rhode Island, United States.  Second International Symposium on Hepatitis Care in Substance Users; September 15-16, 2011, Brussels, Belgium.

Venkatesh KK, DeLong AK, Kantor R, Chapman S, Ingersoll J, Kurpewski J, De Pasquale MP, D'Aquila R, Caliendo AM and Cu-Uvin S. ARV-experienced women with detectable PVL continue to have genital tract HIV-1 RNA shedding after change in treatment regimens.  49th Annual IDSA Meeting; October 20-23, 2011, Boston, MA.

Westley B, Delong A, Soeung S, Chhraing T, Dim S, EM D, Harwell J and Kantor R. High Rates of Treatment Failure Misclassification using 2010 vs. 2006 WHO Guidelines among HIV-infected Children in Siem Reap, Cambodia.  49th Annual IDSA Meeting; October 20-23, 2011, Boston, MA.

Sirivichayakul S, DeLong AK, Wongkunya R, Mekprasan S, Sohn A, Ruxrungtham K, Kantor R and Phanuphak P. Increasing HIV drug resistance among recently infected treatment-naïve MSM in Thailand:  Results from three years of annual surveillance.  6th IAS conference on HIV pathogenesis, treatment and prevention; July 17-20, 2011, Rome, Italy.

Huang A, Hogan J, Istrail S, DeLong A, Katzenstein DA and Kantor R. First-line Antiretroviral Treatment Effects on Resistance Mutation Prevalence in HIV-1 Subtypes.  6th IAS conference on HIV pathogenesis, treatment and prevention; July 17-20, 2011, Rome, Italy.

Dufort EM, Nyandiko WM, DeLong AK, Wools-Kaloustian K, Ayaya S, Vreeman R, Harwell JH and Kantor R. Misclassification of Antiretroviral Therapy Failure Using Immunologic and Clinical Monitoring in HIV Infected Children and Adolescents in Western Kenya.  48th Annual meeting of IDSA; Oct. 21-24, 2010, Vancouver, British Columbia, Canada.

Nijhawan A, DeLong A, Chapman S, Kurpewski J, Ingersoll J, Caliendo A and Cu-Uvin S. Acyclovir Suppresses Genital Tract HSV but not Genital Tract HIV shedding among women on HAART.  48th Annual meeting of IDSA; Oct. 21-24, 2010, Vancouver, British Columbia, Canada.

Huang A, Istrail S, Hogan J, DeLong A and Kantor R. Stratification by HIV-1 subtype does not eliminate systematic geographical variation.  International HIV & Hepatitis Virus Drug Resistance Workshop and Curative Strategies Conference; June 8-12, 2010, Dubrovnik, Croatia.

Liu T, Hogan J and DeLong A. Bounds on ACE and unmeasured confounding bias in observational studies.  2008 Joint Statistics Meeting; Aug 2-7, 2008, Denver, CO.

Liu T, Hogan J and DeLong A. Quantifying bias due to unmeasured confounding in longitudinal HIV cohort studies.  2008 International Biometric Society Eastern North American Region (ENAR); March 16-19, 2008, Arlington, VA.

Beckwith C, Liu T, Bazerman L, DeLong A, DesJardins S and Flanigan T. HIV Risk Behavior Pre- and Post-HIV testing and counseling in Jail.  The 46th Annual Meeting of IDSA; Oct. 25-28, 2008, Washington, DC.

Nijhawan A, Delong A, Chapman S, Rapoza K, Kurpewski J, Cerezo J, Ingersoll J, Caliendo A and Cu-Uvin S. Highly Active Antiretroviral Therapy Suppresses Genital Tract HIV Shedding with or without Chronic HSV Suppression among HIV-1/HSV-2 Co-infected Women.  The 46th Annual Meeting of IDSA; Oct. 25-28, 2008, Washington, DC.

Land S, Cunningham P, Zhou J, Frost K, Katzenstein D, Kantor R, DeLong A, Sayer D, Smith J, Dax EM and Law M. A quality assessment scheme to standardize the outcome of HIV genotypic resistance testing in a group of Asian laboratories.  17th International AIDS Conference (IAS); Aug 3-8, 2008, Mexico City, Mexico.

Moreira C, Delong AK, Liu T, Kurpewski J, Ingersoll J, Caliendo A and Cu-Uvin S. Effect of Treatment of Asymptomatic Bacterial Vaginosis on HIV-1 Shedding in the Genital Tract Among Women on Antiretroviral Therapy.  17th International AIDS Conference (IAS); Aug 3-8, 2008, Mexico City, Mexico.

Taylor L, Gholam P, DeLong A, Rompalo A, Klein R, Schuman P, Gardner L, Carpenter C and Group. HERHS. Occult hepatitis B virus (HBV) and hepatitis C virus (HCV) viremia in women with and at-risk for HIV/AIDS.  17th International AIDS Conference (IAS); Aug 3-8, 2008, Mexico City, Mexico.

Kantor R, Diero L, DeLong A, Kamle L, Muyonga S, Imonyi W, Chan P, Carter EJ and Buziba N. Immunological monitoring as an indicator of virological failure may lead to premature switch to second line HAART regimens.  15th Conference on Retroviruses and Opportunistic Infections (CROI); Feb. 3-6, 2008, Boston, MA.

Wang CC, Liu T, Anderson BL, DeLong AK, Chapman S, Kurpewski J, Ingersoll J, Caliendo AM and Cu-Uvin S. Association between genital tract HIV-1 RNA shedding and mucosal inflammation among women on effective ART with undetectable plasma viral load.  15th Conference on Retroviruses and Opportunistic Infections (CROI); Feb. 3-6, 2008, Boston, MA.

Beckwith CG, Desjardins SF, DeLong AK and Flanigan TP. HIV Risk Behavior Pre- and Post-HIV Testing in Jail: A Preliminary Analysis of Methodological Issues.  National HIV Prevention Conference: Promoting Synergy Between Science and Program; Dec 2-5, 2007, Atlanta, GA.

Anderson BL, Liu T, DeLong AK, Ingersoll J, Wang CC, Kurpewski J, Caliendo A and Cu-Uvin S. Genital tract shedding of HIV-1 RNA and lower genital tract infections may be linked by inflammation.  The 45th Annual Meeting of IDSA; October 4-7, 2007, San Diego, CA.

Cu-Uvin S, DeLong A, Rezk N, Hogan J, Burtwell H, Chapman S, Moreira C, Kurpewski J, Ingersoll J, Caliendo A and Kashuba A. Antiretroviral drug concentrations in the genital tract of HIV-infected women.  34th Annual Scientific Meeting of  Infectious Diseases Society for Obstetrics and Gynecology  (IDSOG); August 9-11, 2007, Boston, MA.

Cu-Uvin S, DeLong A, Harwell J, Hogan J, Ingersoll J, Kurpewski J, Chapman S, Cerezo J, Moreira C and Caliendo A. Genital Tract HIV-1 RNA Shedding Among Women on Highly Active Antiretroviral Therapy with Below Detectable Plasma Viral Load.  34th Annual Scientific Meeting of Infectious Diseases Society for Obstetrics and Gynecology (IDSOG); August 9-11, 2007, Boston, MA.

Anderson BL, DeLong A, Liu T, Wang CC, Kurpewski J and Cu-Uvin S. Association between genital tract white blood cells and viral shedding among HIV-infected women in the absence of genital infections.  34th Annual Scientific Meeting of Infectious Diseases Society for Obstetrics and Gynecology (IDSOG); August 9-11, 2007, Boston, MA.

Mitty J, DeLong AK, Bazerman L and Macalino G. Risk Behaviors among HIV-Positive Active Substance Users Enrolled in an Adherence Intervention.  International Conference on HIV Treatment Adherence; Mar. 28-30, 2007, Jersey City, NJ.

Cu-Uvin S, DeLong A, Rezk N, Hogan J, Burtwell H, Chapman S, Moreira C, Kurpewski J, Ingersoll J, Caliendo A and Kashuba A. Antiretroviral drug concentrations in the genital tract of HIV-infected women. .  14th Conference on Retroviruses and Opportunistic Infections (CROI); Feb. 24-28, 2007, Los Angeles, CA.

Cu-Uvin S, Harwell J, Delong A, Hogan J, Burtwell H, Ingersoll J, Moreira C, Chapman S, Kurpewski J, Cerezo J and Caliendo A. Genital Tract HIV-1 RNA Shedding and Asymptomatic HSV Shedding Among Women on Highly Active Antiretroviral Therapy.  International AIDS Society (IAS) Conference on HIV pathogenesis, treatment and prevention; July 22-25, 2007, Sydney Australia.

Mitty JA, Macalino GE, Bazerman LB, DeLong AK, Hogan JW, Loewenthal HG and Flanigan TP. A randomized controlled trial of directly observed HAART (DOT) vs. standard of care (SOC) among active substance users.  43rd Annual Meeting of the Infectious Diseases Society of America (IDSA); Oct 5-9, 2005, San Francisco, CA.

Rich JD, DeLong AK, Hogan JW, Mehrotra M, Reinert SE and Wolf F. Low Risk Syringe Sharing and Re-Use After Syringe Legalization in Rhode Island.  Annual Meeting of the American Public Health Association (APHA); Nov 5-9, 2005, New Orleans, LA.

Kantor R, DeLong A, Shafer RW, Carvalho AP, Wynhoven B, Cane P, Sirivichayakul S, Soares MA, Snoeck J, Rudich H, Rodrigues R, Holguin A, Ariyoshi K, Bouzas MB, Cahn P, Sugiura W, Soriano V, Brigido LF, Grossman Z, Morris L, Vandamme AM, Tanuri A, Phanuphak P, Weber J, Pillay D, Harrigan PR, Camacho R, Schapiro JM, Hogan J and Katzenstein DA. Selection of Resistance Following First-line Antiretroviral Regimens Among HIV-1 Subtypes.  14th International HIV Drug Resistance Workshop; June 7-11, 2005, Quebec City, Quebec, Canada.

Gholam PM, Taylor LE, DeLong AK, Lazarus TS, Cintron V, Mayer KH, Klein RS, Schuman PC, Rompalo AM, Carpenter CJ and Wands JR. Occult HBV and HCV viremia in women at risk for and with HIV infection.  57th Annual Meeting of the American Association for the Studyof Liver Diseases (AASLD); October 27-31, 2006, Boston, MA.

Cu-Uvin S, DeLong A, Harwell J, Hogan J, Ingersoll J, Kurpewski J, Chapman S, Cerezo J, Moreira C and Caliendo A. Genital Tract HIV-1 RNA Shedding Among Women on Highly Active Antiretroviral Therapy with Below Detectable Plasma Viral Load. 44th Annual Meeting of the Infectious Diseases Society of America (IDSA); October 12-15 2006, Toronto, Canada.

 

 




© 2015 All Rights Reserved | Brown University Center for Statistical Sciences | Phone: 401.863.9181 | Fax: 401.863.9182 | center@stat.brown.edu
Search provided by Google © | Sitemap